Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: Insights from the prospective PROSPECT registry

EuroIntervention

Volumn 11, Issue 13, 2016, Pages 1468-1474

  Iñiguez, Andrés ^a   Brener, Sorin J ^b,c   Jiménez, Victor A ^a   Maehara, Akiko ^c,d   Mintz, Gary S ^c   Xu, Ke ^c   Weisz, Giora ^c,d,e   Lansky, Alexandra J ^f   De Bruyne, Bernard ^g   Serruys, Patrick W ^h   Stone, Gregg W ^c,d  

^a HOSPITAL DO MEIXOEIRO   (Spain)

^b NEW YORK METHODIST HOSPITAL   (United States)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d Department of Medicine   (United States)

^e SHAARE ZEDEK MEDICAL CENTER   (Israel)

^f YALE UNIVERSITY MEDICAL CENTER   (United States)

^g CARDIOVASCULAR CENTER   (Belgium)

^h ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Acute coronary syndromes; Outcomes; Percutaneous coronary intervention; Virtual histology intravascular ultrasound

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGE; ANGINA PECTORIS; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART DEATH; HEART INFARCTION; HISTOPATHOLOGY; HOSPITAL READMISSION; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; AGED; CLINICAL TRIAL; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROCEDURES; REGISTER; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84964801709     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV11I13A285     Document Type: Article

References (11)

1. Morrow DA. Cardiovascular risk prediction in patients with stable and unstable coronary heart disease. Circulation. 2010;121: 2681-91.
2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129:e28-e292.
3. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW; PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226-35.
4. Maehara A, Cristea E, Mintz GS, Lansky AJ, Dressler O, Biro S, Templin B, Virmani R, de Bruyne B, Serruys PW, Stone GW. Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses. JACC Cardiovasc Imaging. 2012;5:S1-9.
5. Marso SP, Frutkin AD, Mehta SK, House JA, McCrary JR, Klauss V, Lerman A, Leon MB, Nair A, Margolis P, Erbel R, Nasu K, Schiele F, Margolis J. Intravascular ultrasound measures of coronary atherosclerosis are associated with the Framingham risk score: an analysis from a global IVUS registry. EuroIntervention. 2009;5:212-8.
6. Garcia-Garcia HM, Mintz GS, Lerman A, Vince DG, Margolis MP, van Es GA, Morel MA, Nair A, Virmani R, Burke AP, Stone GW, Serruys PW. Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. EuroIntervention. 2009;5:177-89.
7. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Gabriel Steg P, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-51.
8. Labinaz M, Mathias J, Pieper K, Granger CB, Lincoff AM, Moliterno DJ, Van de Werf F, Simes J, White HD, Simoons ML, Califf RM, Topol EJ, Armstrong PW, Harrington RA. Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials. Eur Heart J. 2005;26:128-36.
9. Santos JF, Ferreira J, Aguiar C, Goncalves P, Raposo L, Almeida M, Seabra-Gomes R. Prognosis of non-ST-segment elevation acute coronary syndrome in patients with prior percutaneous coronary intervention. Rev Port Cardiol. 2005;24:805-16.
10. Elbarasi E, Goodman SG, Yan RT, Welsh RC, Kornder J, Wong GC, Dery JP, Anderson F, Gore JM, Fox KA, Yan AT; Canadian Acute Coronary Syndrome Registries I and II (ACS I and ACS II); Canadian Global Registry of Acute Coronary Events (GRACE/expanded-GRACE) Investigators. Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization. Am Heart J. 2010;159:40-6.
11. Kelly CR, Weisz G, Maehara A, Mintz GS, Mehran R, Lansky AJ, Parise H, de Bruyne B, Serruys PW, Stone GW. Relation of C-reactive protein levels to instability of untreated vulnerable coronary plaques (from the PROSPECT Study). Am J Cardiol. 2014;114:376-83.